Public Health Emergency - Leading a Nation Prepared
Qiagen will develop a COVID-19 test, QIAstat-Dx RPS2, to be added to the QIAstat-Dx Respiratory Panel. The device is used to run FDA-cleared tests for 21 respiratory pathogens. The device features easy-to-use molecular testing with novel workflows.
On March 30, 2020, FDA issued an Emergency Use Authorization (EUA) to allow QIAGEN's QIAstat-Dx Respiratory SARS-CoV-2 Panel to be used to detect and differentiate nucleic acid from multiple respiratory viral and bacterial organisms, including the SARS-CoV-2 virus.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages